Creo Medical Group (CREO) Competitors GBX 12.50 -0.75 (-5.66%) As of 08/1/2025 12:42 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock CREO vs. EKF, IUG, NCYT, IHC, POLX, AVO, RUA, SUN, MHC, and MXCTShould you be buying Creo Medical Group stock or one of its competitors? The main competitors of Creo Medical Group include EKF Diagnostics (EKF), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Polarean Imaging (POLX), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), MyHealthChecked (MHC), and MaxCyte (MXCT). These companies are all part of the "medical devices" industry. Creo Medical Group vs. Its Competitors EKF Diagnostics Intelligent Ultrasound Group Novacyt Inspiration Healthcare Group Polarean Imaging Advanced Oncotherapy RUA Life Sciences Surgical Innovations Group MyHealthChecked MaxCyte EKF Diagnostics (LON:EKF) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk. Does the media favor EKF or CREO? In the previous week, EKF Diagnostics had 2 more articles in the media than Creo Medical Group. MarketBeat recorded 2 mentions for EKF Diagnostics and 0 mentions for Creo Medical Group. EKF Diagnostics' average media sentiment score of 0.23 beat Creo Medical Group's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the media. Company Overall Sentiment EKF Diagnostics Neutral Creo Medical Group Neutral Do institutionals and insiders believe in EKF or CREO? 70.3% of EKF Diagnostics shares are owned by institutional investors. Comparatively, 56.1% of Creo Medical Group shares are owned by institutional investors. 5.2% of EKF Diagnostics shares are owned by insiders. Comparatively, 22.4% of Creo Medical Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more volatility and risk, EKF or CREO? EKF Diagnostics has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, Creo Medical Group has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Is EKF or CREO more profitable? EKF Diagnostics has a net margin of 9.37% compared to Creo Medical Group's net margin of -73.93%. EKF Diagnostics' return on equity of 7.03% beat Creo Medical Group's return on equity.Company Net Margins Return on Equity Return on Assets EKF Diagnostics9.37% 7.03% 5.27% Creo Medical Group -73.93%-41.79%-20.09% Which has better earnings & valuation, EKF or CREO? EKF Diagnostics has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEKF Diagnostics£49.91M2.75£4.68M£1.0728.75Creo Medical Group£33.87M1.49-£25.04M-£6.32-1.98 SummaryEKF Diagnostics beats Creo Medical Group on 11 of the 13 factors compared between the two stocks. Get Creo Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CREO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CREO vs. The Competition Export to ExcelMetricCreo Medical GroupMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£50.53M£3.44B£5.52B£3.03BDividend YieldN/A2.44%4.74%5.02%P/E Ratio-1.9878.8228.99176.75Price / Sales1.49101.43440.51264,362.45Price / Cash2.4315.9935.0727.97Price / Book0.953.938.254.53Net Income-£25.04M£132.05M£3.25B£5.90B7 Day Performance-9.09%-2.91%-3.75%12.58%1 Month Performance-1.96%3.92%2.99%4.67%1 Year Performance-56.90%8.85%25.34%72.88% Creo Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CREOCreo Medical GroupN/AGBX 12.50-5.7%N/A-57.4%£50.53M£33.87M-1.98279EKFEKF DiagnosticsN/AGBX 29.20+0.3%N/A+16.2%£129.79M£49.91M27.17356News CoverageIUGIntelligent Ultrasound GroupN/AN/AN/AN/A£42.76M£6.57M-18.9165NCYTNovacytN/AGBX 40.40+0.2%N/A-12.3%£27.92M£18.12M-0.74120News CoverageIHCInspiration Healthcare GroupN/AGBX 21.25-1.2%N/A-26.9%£18.41M£42.87M-1.46224POLXPolarean ImagingN/AGBX 1.10+2.3%N/A-39.8%£16.15M£5.21M-0.2828Gap DownAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.30-3.8%N/A+5.5%£7.01M£4.05M-2.6348Gap DownSUNSurgical Innovations GroupN/AGBX 0.70flatN/A-0.6%£6.53M£12.54M-21.1180Gap DownHigh Trading VolumeMHCMyHealthCheckedN/AGBX 12.05-3.6%N/A+33.3%£6.27M£9.43M-6.0116Gap DownMXCTMaxCyteN/AGBX 2.25-0.9%N/A-99.4%£2.97M£57.52M-0.0880High Trading Volume Related Companies and Tools Related Companies EKF Diagnostics Competitors Intelligent Ultrasound Group Competitors Novacyt Competitors Inspiration Healthcare Group Competitors Polarean Imaging Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors Surgical Innovations Group Competitors MyHealthChecked Competitors MaxCyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CREO) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Creo Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CREO Stock Alerts